BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 18568994)

  • 41. Distribution of fucosubstance in kidney and related neoplasms. Absence of lectin-reactive alpha-fucose from the vasculature of bilateral Wilm's tumors.
    Hennigar RA; Sens DA; Othersen HB; Garvin AJ
    Arch Pathol Lab Med; 1988 Sep; 112(9):908-13. PubMed ID: 2843140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical expression of neural cell adhesion molecule in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices.
    Kapur P; Rakheja D
    Pediatr Dev Pathol; 2011; 14(1):16-9. PubMed ID: 20524836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adult Wilms' tumour. A case report with immunohistochemical studies.
    Sápi Z; Svastics E
    Acta Morphol Hung; 1990; 38(1):55-60. PubMed ID: 1708644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
    Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
    Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
    Cheah PL; Looi LM; Chan LL
    Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
    Salama A; Kamel A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
    D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
    J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center.
    Weeks DA; Beckwith JB; Mierau GW; Luckey DW
    Am J Surg Pathol; 1989 Jun; 13(6):439-58. PubMed ID: 2543225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor.
    Schlomm T; Gunawan B; Schulten HJ; Sander B; Thangavelu K; Graf N; Leuschner I; Ringert RH; Füzesi L
    Clin Cancer Res; 2005 Jun; 11(12):4382-7. PubMed ID: 15958621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytologic characteristics of Wilms' tumors in fine needle aspirates. A study of ten cases.
    Quijano G; Drut R
    Acta Cytol; 1989; 33(2):263-6. PubMed ID: 2538987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botryoid Wilms' tumor of the renal pelvis extending into the bladder.
    Nagahara A; Kawagoe M; Matsumoto F; Tohda A; Shimada K; Yasui M; Inoue M; Kawa K; Hamana K; Nakayama M
    Urology; 2006 Apr; 67(4):845.e15-7. PubMed ID: 16600349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Derivation and characterization of a Wilms' tumour cell line, WiT 49.
    Alami J; Williams BR; Yeger H
    Int J Cancer; 2003 Nov; 107(3):365-74. PubMed ID: 14506735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular matrix and epithelial differentiation of Wilms' tumor.
    Sariola H; Ekblom P; Rapola J; Vaheri A; Timpl R
    Am J Pathol; 1985 Jan; 118(1):96-107. PubMed ID: 2981473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of age and nephrectomy on metastatic patterns in Wilms' tumors.
    Saitoh H; Shiramizu T; Nakamura K; Satoh T
    Tokai J Exp Clin Med; 1982 May; 7(3):345-54. PubMed ID: 6289493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
    Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
    Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased tissue factor expression and poor nephroblastoma prognosis.
    Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
    J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.